Generali Investments CEE’s Zimmer Biomet ZBH Stock Holding History

Generali Investments CEE’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$525K	Hold	6,100	–	–	0.02%	348
2026 Q1	$552K	Hold	6,100	–	–	0.03%	342
2025 Q4	$549K	Hold	6,100	–	–	0.04%	294
2025 Q3	$601K	Hold	6,100	–	–	0.05%	277
2025 Q2	$556K	Hold	6,100	–	–	0.05%	280
2025 Q1	$690K	Hold	6,100	–	–	0.06%	257
2024 Q4	$644K	Buy	+6,100	New	+$655K	0.07%	241

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Generali Investments CEE's ZBH Position: Q2 2026 in Review

Generali Investments CEE held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 6,100 shares worth $525K. The position accounts for 0.02% of the portfolio, ranked #348.

Generali Investments CEE first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $690K in Q1 2025. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Generali Investments CEE held 6,100 shares of Zimmer Biomet worth $525K as of Q2 2026.
Generali Investments CEE left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.02% of Generali Investments CEE's portfolio in Q2 2026, its #348 holding.
Generali Investments CEE first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
Generali Investments CEE's Zimmer Biomet position peaked at $690K in Q1 2025.
150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.